Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

NCT04446962

Conditions
Central Nervous System Neoplasms, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, +16 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CH côte Basque Bayonne, France
  • CHU Besançon Besançon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

NCT06381141

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Mt. Sinai New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

NCT06285370

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Peking University First Hospital, Department of Dermatology and Venereology Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center, Department of Medical Oncology Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • The Affiliated Hospital of Inner Mongolia Medical University Hohhot, Inner Mongolia, China
View Trial Details

Related conditions